Supplementary Figure 1 from Combination ATR (ceralasertib) and PARP (olaparib) Inhibitor (CAPRI) Trial in Acquired PARP Inhibitor–Resistant Homologous Recombination–Deficient Ovarian Cancer

<p>Trial schema</p>

Uloženo v:

Podrobná bibliografie
Hlavní autor:	Stephanie L. Wethington (16354020) (author)
Další autoři:	Payal D. Shah (14942077) (author), Lainie Martin (16354023) (author), Janos L. Tanyi (15047976) (author), Nawar Latif (16354026) (author), Mark Morgan (16354029) (author), Drew A. Torigian (15047964) (author), Diego Rodriguez (16354032) (author), Simon A. Smith (16354035) (author), Emma Dean (16354038) (author), Susan M. Domchek (14944434) (author), Ronny Drapkin (14937867) (author), Ie-Ming Shih (14964062) (author), Eric J. Brown (16354041) (author), Wei-Ting Hwang (15045089) (author), Deborah K. Armstrong (15134754) (author), Stephanie Gaillard (14947156) (author), Robert Giuntoli (16354044) (author), Fiona Simpkins (15048000) (author)
Vydáno:	2025
Témata:	Cancer Therapeutic Research and Development Clinical Research and Trials Clinical Trial Results Drug Resistance Gynecological Cancers Ovarian cancer
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!

Podobné jednotky